NCT ID | NCT02747004 |
Title | A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer (nextMONARCH 1) |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | yes |
Sponsors | Eli Lilly and Company |
Indications | |
Therapies | |
Age Groups: | adult |